A summary of meeting proceedings for ‘Measuring immune responses in non-human primates for drug development—Opportunities and challenges for predicting human efficacy and immunotoxicity’

References

• Altman, J. D., Moss, P. A., Goulder, P. J., Barouch, D. H., Mcheyzer-Williams, M. G., Bell, J. I., McMichael, A. J., and Davis, M. M. 1996. Phenotypic analysis of antigen-specific T-lymphocytes. Science 274:94–96.
   PubMed Web of Science ®Google Scholar
• Andrade, M. R., Yee, J., Barry, P., Spinner, A., Roberts, J. A., Cabello, P. H., Leite, J. P., and Lerche, N. W. 2003. Prevalence of antibodies to selected viruses in a long-term closed breeding colony of rhesus macaques (Macaca mulatta) in Brazil. Am. J Primatol. 59:123–128.
   PubMed Web of Science ®Google Scholar
• Asher, D. M., Gibbs, C. J., Lang, D. J., Gajdusek, D. C., and Chanock, R. M. 1974. Persistent shedding of cytomegalovirus in the urine of healthy Rhesus monkeys. Proc. Soc. Exp. Biol. Med. 145:794–801.
   PubMed Web of Science ®Google Scholar
• Barten, M. J., Dhein, S., Chang, H., Bittner, H. B., Tarnok, A., Rahmel, A., Mohr, F. W., and Gummert, J. F. 2003. Assessment of immunosuppressive drug interactions: Inhibition of lymphocyte function in peripheral human blood. J Immunol. Meth. 283:99–114.
   PubMed Web of Science ®Google Scholar
• Baskin, G. B. 1987. Disseminated cytomegalovirus infection in immunodeficient rhesus monkeys. Am. J Pathol.129:345–352.
   PubMed Web of Science ®Google Scholar
• Baskin, G. B., Murphey-Corb, M., Watson, E. A., and Martin, L. N. 1988. Necropsy findings in rhesus monkeys experimentally infected with cultured simian immunodeficiency virus (SIV)/delta. Vet. Pathol. 25:456–467.
   PubMed Web of Science ®Google Scholar
• Bendall, S. C., Simonds, E. F., Qui P., Amir, E. D., Krutzik, P. O., Finck, R., Bruggner, R. V., Melamed, R., Trejo, A., Ornatsky, O., Balderas, R. S., Plevritis, S. K., Sachs, K., Pe’er, D., Tanner, S. D., and Nolan, G. P. 2011. Single-cell mass cytometry of differential immune and drug responses across a human hematopoetic continuum. Science 332:687–696.
   PubMed Web of Science ®Google Scholar
• Berger, J. R., and Houff, S. 2009. Opportunistic infections and other risks with newer multiple sclerosis therapies. Ann. Neurol. 65:367–377.
   PubMedGoogle Scholar
• Betts, M. R., Brenchley, J. M., Price, D. A., De Rosa, S. C., Douek, D. C., Roederer, M., and Koup, R. A. 2003. Sensitive and viable identification of antigen-specific CD8+ T-cells by a flow cytometric assay for degranulation. J Immunol. Meth. 281:65–78.
   PubMed Web of Science ®Google Scholar
• Bolton, D. L., and Roederer, M. 2009. Flow cytometry and the future of vaccine development. Expert Rev. Vaccines 8:779–789.
   PubMed Web of Science ®Google Scholar
• Budde, M. L., Wiseman, R. W., Karl, J. A., Hanczaruk, B., Simen, B. B., and O’ Connor, D. H. 2010. Characterization of Mauritian cynomolgus macaque major histocompatibility complex Class I haplotypes by high-resolution pyrosequencing. Immunogenetics 62:773–780.
   PubMedGoogle Scholar
• Bugelski, P. J., Volk, A., Walker, M. R., Krayer, J. H., Martin, P., and Descotes, J. 2010. Critical review of preclinical approaches to evaluate the potential of immunosuppressive drugs to influence human neoplasia. Int. J Toxicol. 29:435–466.
   PubMed Web of Science ®Google Scholar
• Burwitz, B. J., Pendley, C. J., Greene, J. M., Detmer, A. M., Lhost, J. J., Karl, J. A., Piaskowski, S. M., Rudersdorf, R. A., Wallace, L. T., Bimber, B. N., Loffredo, J. T., Cox, D. G., Bardet, W., Hildebrand, W., Wiseman, R. W., O’ Connor, S. L., and O’ Connor, D. H. 2009. Mauritian cynomolgus macaques share two exceptionally common major histocompatibility complex Class I alleles that restrict simian immunodeficiency virus-specific CD8+ T-cells. J Virol. 83:6011–6019.
   PubMedGoogle Scholar
• Caldwell, R., Guirguis, M., and Kornbrust, E. 2007. Evaluation of various keyhole limpet hemocyanin dosing regimens for the cynomolgus monkey TDAR assay. The Toxicologist Abstract #1723.
   Google Scholar
• Carfi, M., Gennari, A., Malerba, I., Corsini, E., Pallardy, M., Pieters, R., van Loveren, H., Vohr, H. W., Hartung, T, and Gribaldo, L. 2007. In vitro tests to evaluate immunotoxicity: A preliminary study. Toxicology 229:11–22.
   PubMed Web of Science ®Google Scholar
• Carville, A., and Mansfield, K. G. 2008. Comparative pathobiology of macaque lympho-cryptoviruses. Comp. Med. 58:57–67.
   PubMed Web of Science ®Google Scholar
• Chan, K. S., and Kaur, A. 2007. Flow cytometric detection of degranulation reveals phenotypic heterogeneity of degranulating CMV-specific CD8+ T-lymphocytes in rhesus macaques. J Immunol. Meth. 325:20–34.
   PubMedGoogle Scholar
• Chattopadhyay, P. K., Yu, J., and Roederer, M. 2005. A live-cell assay to detect antigen-specific CD4+ T-cells with diverse cytokine profiles. Nat. Med. 11:1113–1117.
   PubMed Web of Science ®Google Scholar
• Cohen, G. B., Kaur, A., and Johnson, R. P. 2005. Isolation of viable antigen-specific CD4 T-cells by CD40L surface trapping. J Immunol. Meth. 302:103–115.
   PubMedGoogle Scholar
• Cordoba, F., Wieczorek, G., Preussing, E., and Bigaud, M. 2008. Modeling of delayed type hypersensitivity (DTH) in the non-human primate (NHP). Drug Discov Today: Dis Models 5:63–71.
   Google Scholar
• CPMP (Committee for Proprietary Medicinal products). 2000. Note for guidance on repeated dose toxicity. CPMP/SWP/1042/99.
   Google Scholar
• Dumont, F. J., Melino, M. R., Staruch, M. J., Koprak, S. L., Fischer, P. A., and Sigal, N. H. 1990. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T-cells. J Immunol. 144:1418–1424.
   PubMed Web of Science ®Google Scholar
• FDA (Food and Drug Administration, Center for Drug Evaluation and Research). 2002. Guidance for Industry. Immunotoxicology evaluation of investigational new drugs. FDA.
   Google Scholar
• Florese, R. H., Wiseman, R. W., Venzon, D., Karl, J. A., Demberg, T., Larsen, K., Flanary, L., Kalyanaraman, V. S., Pal, R., Titi, F., Patterson, L. J., Heath, M. J., O’ Connor, D. H., Cafaro, A., Ensoli, B., and Robert-Guroff, M. 2008. Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infection. Vaccine 26:3312–3321.
   PubMedGoogle Scholar
• Fogg, M. H., Kaur, A., Cho, Y. G., and Wang, F. 2005. The CD8+ T-cell response to an Epstein-Barr virus-related gammaherpesvirus infecting rhesus macaques provides evidence for immune evasion by the EBNA-1 homologue. J Virol. 79:12681–12691.
   PubMedGoogle Scholar
• Frentsch, M., Arbach, O., Kirchoff, D., Moewes, B., Worm, M., Rothee, M., Scheffold, A., and Thiel, A. 2005. Direct access to CD4+ T-cells specific for defined antigens according to CD154 expression. Nat. Med. 11:1118–1124.
   PubMed Web of Science ®Google Scholar
• Furst, D. E. 2010. The risk of infections with biologic therapies for rheumatoid arthritis. Semin. Arthritis Rheum. 39:327–346.
   PubMed Web of Science ®Google Scholar
• Gauduin, M. C., Kaur, A., Ahmad, S., Yilma, T., Lifson, J. D., and Johnson, R. P. 2004. Optimization of intracellular cytokine staining for the quantitation of antigen-specific CD4+ T-cell responses in rhesus macaques. J Immunol. Meth..288:61–79.
   PubMedGoogle Scholar
• Hadrup, S. R., and Schumacher, T. N. 2010. MHC-based detection of antigen-specific CD8+ T-cell responses. Cancer Immunol. Immunother. 59:1425–1433.
   PubMedGoogle Scholar
• Haggerty, H. 2007. Immunotoxicity testing in non-rodent species. J Immunotoxicol. 4:165–169.
   PubMed Web of Science ®Google Scholar
• Hansen, S. G., Strelow, L. I., Franchi, D. C., Anders, D. G., and Wong, S. W. 2003. Complete sequence and genomic analysis of rhesus cytomegalovirus. J Virol. 77:6620–6636.
   PubMed Web of Science ®Google Scholar
• Hislop A. D., Taylor G. S., Sauce D., and Rickinson A. B. 2007. Cellular responses to viral infection in humans: Lessons from Epstein-Barr virus. Annu. Rev. Immunol. 25:587–617.
   PubMed Web of Science ®Google Scholar
• ICH (International Conference on Harmonization). 2006. Guidance for Industry. S8 Immunotoxicity Studies for Human Pharmaceuticals.
   Google Scholar
• Imamura, T., Iyama, K., Takeya, M., Kambara, T., and Nakamura, S. 1993. Role of macrophage tissue factor in the development of the delayed hypersensitivity reaction in monkey skin. Cell. Immunol. 152:614–622.
   PubMedGoogle Scholar
• Johnson, D. E., Smith, D. A., and Park, B. K. 2010. Immunomodulatory therapies and the risk of opportunistic infections. Curr. Opin. Drug Discov. Devel. 13:20–22.
   PubMedGoogle Scholar
• Kaur, A., Daniel, M. D., Hempel, D., Lee-Parritz, D., Hirsch, M. S., and Johnson, R. P. 1996. Cytotoxic T-lymphocyte responses to cytomegalovirus in normal and simian immuno-deficiency virus-infected rhesus macaques. J Virol. 70:7725–7733.
   PubMedGoogle Scholar
• Kaur, A., Hale, C. L., Noren, B., Kassis, N., Simon, M. A., and Johnson R. P. 2002. Decreased frequency of cytomegalovirus (CMV)-specific CD4+ T-lymphocytes in simian immuno-deficiency virus-infected rhesus macaques: inverse relationship with CMV viremia. J Virol. 76:3646–3658.
   PubMedGoogle Scholar
• Kaur, A., Kassis, N., Hale, C. L., Simon, M., Elliott, M., Gomez-Yafal, A., Lifson, J. D., Desrosiers, R. C., Wang, F., Barry, P., Mach, M., and Johnson, R. P. 2003. Direct relationship between suppression of virus-specific immunity and emergence of cytomegalovirus disease in simian AIDS. J Virol. 77:5749–5758.
   PubMed Web of Science ®Google Scholar
• Kirk, S. A., Fraser, S. R., Gordon, D., and Templeton, A. 2008. Evaluation of the T-cell dependent antibody response (TDAR) to tetanus toxoid (TT), in the cynomolgus monkey, in the presence of a known immunosuppressant. The Toxicologist. Abstract #2134.
   Google Scholar
• Kotton, C. N., and Fishman, J. A. 2005. Viral infection in the renal transplant recipient. J Am. Soc. Nephrol. 16:1758–1774.
   PubMed Web of Science ®Google Scholar
• Krathen, M. S., Gottlieb, A. B., and Mease, P. J. 2010. Pharmacologic immunomodulation and cutaneous malignancy in rheumatoid arthritis, psoriasis, and psoriatic arthritis. J Rheumatol. 37:2205–2215.
   PubMed Web of Science ®Google Scholar
• Krutzik, P. O., and Nolan, G. P. 2006. Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nat. Meth. 3:361–368.
   PubMed Web of Science ®Google Scholar
• Krutzik, P. O., Clutter, M. R., Trejo, A., and Nolan, G. P. 2011. Fluorescent cell barcoding for multiplex flow cytometry. Curr. Protocol Cytom. Chapter 6, Unit 6 31.
   PubMedGoogle Scholar
• Kumar, A., Weiss, W., Tine, J. A., Hoffman, S. L., and Rogers, W. O. 2001. ELISPOT assay for detection of peptide specific IFNγ-secreting cells in rhesus macaques. J Immunol. Meth. 247:49–60.
   PubMedGoogle Scholar
• Lebrec, H., Roger, R., Blot, C., Burleson, G. R., Bohuoun, C., and Pallardy, M. 1995. Immunotoxicological investigation using pharmaceutical drugs. In vitro evaluation of immune effects using rodent or human immune cells. Toxicology 96:147–156.
   PubMed Web of Science ®Google Scholar
• Lebrec, H., Cowan, L., Lagrou, M., Krejsa, C., Neradilek, M., Polissar, N., Black, L., and Bussiere, J. 2011. An inter-laboratory retrospective analysis of immunotoxicological endpoints in non-human primates: T-Cell-dependent antibody responses. J Immunotoxicol. 8:238–250.
   PubMed Web of Science ®Google Scholar
• Luster, M. I., Portier, C., Pait, D. G., Rosenthal, G., Germolec, D. R., Corsini, E., Blaylock, B. L., Pollock, P., Kouchi, Y., Craig, W., White, K. L. Munson, A. E., and Comment, C. E. 1993. Risk assessment in immunotoxicology. II. Relationships between immune and host resistance tests. Fundam. Appl. Toxicol. 21:71–82.
   PubMedGoogle Scholar
• Luster, M. I., Portier, C., Pait, D. G., White, K. L. Gennings, C., Munson, A. E., and Rosenthal, G. J. 1992. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol. 18:200–210.
   PubMedGoogle Scholar
• McCutcheon, M., Wehner, N., Wensky, A., Kushner, M., Doan, S., Hsiao, L., Calabresi, P., Ha, T., Tran, T. V., Tate, K. M., Winkelhake, J., and Spack, E. G. 1997. A sensitive ELISPOT assay to detect low-frequency human T-lymphocytes. J Immunol. Meth. 210:149–166.
   PubMed Web of Science ®Google Scholar
• Moghaddam, A., Rosenzweig, M., Lee-Parritz, D., Annis, B., Johnson, R. P., and Wang, F. 1997. An animal model for acute and persistent Epstein-Barr virus infection. Science 276:2030–2033.
   PubMed Web of Science ®Google Scholar
• Mueller, N. J., Barth, R. N., Yamamoto, S., Kitamura, H., Patience, C., Yamada, K., Cooper, D. K., Sachs, D. H., Kaur, A., and Fishman, J. A. 2002. Activation of cytomegalovirus in pig-to-primate organ xenotransplantation. J Virol. 76:4734–4740.
   PubMedGoogle Scholar
• O’ Connor, S. L., Blasky, A. J., Pendley, C. J., Becker, E. A., Wiseman, R. W., Karl, J. A., Hughes, A. L., and O’ Connor, D. H. 2007. Comprehensive characterization of MHC Class II haplotypes in Mauritian cynomolgus macaques. Immunogenetics 59:449–462.
   PubMedGoogle Scholar
• Oelke, M., and Schneck, J. P. 2010. Overview of a HLA-Ig based “Lego-like system” for T-cell monitoring, modulation and expansion. Immunol. Res. 47:248–256.
   PubMedGoogle Scholar
• Oelke, M., Maus, M. V., Didiano, D., June, C. H., Mackensen, A., and Schneck, J. P. 2003. Ex vivo induction and expansion of antigen-specific cytotoxic T-cells by HLA-Ig-coated artificial antigen-presenting cells. Nat. Med. 9:619–624.
   PubMed Web of Science ®Google Scholar
• Ornatsky, O., Bandura, D., Baranov, V., Nitz, M., Winnik, M. A., and Tanner, S. 2010. Highly multiparametric analysis by mass cytometry. J. Immunol. Meth. 361:1–20.
   PubMed Web of Science ®Google Scholar
• Pearson, T. C., Trambley, J., Odom, K., Anderson, D. C., Cowan, S., Bray, R., Lin, A., Hollenbaugh, D., Aruffo, A., Siadak, A. W., Strobert, E., Hennigar, R., and Larse, C. P. 2002. Anti-CD40 therapy extends renal allograft survival in rhesus macaques. Transplantation 74:933–940.
   PubMed Web of Science ®Google Scholar
• Piccotti, J., Alvey, J., Reindel, J., and Guzman, R. 2005. T-Cell-dependent antibody response: Assay development in cynomolgus monkeys. J. Immunotoxicol. 2:191–196.
   PubMedGoogle Scholar
• Picotti, J. R. 2008. T-cell dependent antibody response tests. In: Immunotoxicology Strategies for Pharmaceutical Safety Assessment, Danuta J.H., and Bussiere J., Eds., New York: John Wiley and Sons, Inc., pp. 67–76.
   Google Scholar
• Pitcher, C. J., Hagen, S. I., Walker, J. M., Lum, R., Mitchell, B. L., Maino, V. C., Axthelm, M. K., and Picker, L. J. 2002. Development and homeostasis of T-cell memory in rhesus macaque. J Immunol. 168:29–43.
   PubMedGoogle Scholar
• Radu, C. G., Shu, C. J., Nair-Gill, E., Shelly, S. M., Barrio, J. R., Satyamurthy, N., Phelops, M. E., and Witte, O. N. 2008. Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [18F]-labeled 2′-deoxycytidine analog. Nat. Med. 14:783–788.
   PubMed Web of Science ®Google Scholar
• Ribas, A., Benz, M. R., Allen-Auerbach, M. S., Radu, C., Chmielowski, B., Seja, E., Williams, J. L., Gomez-Navarro, J., McCarthy, T., and Czernin, J. 2010. Imaging of CTLA4 blockade-induced cell replication with [18F]-FLT PET in patients with advanced melanoma treated with tremelimumab. J Nucl. Med. 51:340–346.
   PubMedGoogle Scholar
• Rivailler, P., Carville, A., Kaur, A., Rao, P., Quink, C., Kutok, J. L., Westmoreland, S., Klumpp, S., Simon, M., Aster, J. C., and Wang, F. 2004. Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: An animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host. Blood 104:1482–1489.
   PubMed Web of Science ®Google Scholar
• Rivailler, P., Kaur, A., Johnson, R. P., and Wang, F. 2006. Genomic sequence of rhesus cytomegalovirus 180.92: Insights into the coding potential of rhesus cytomegalovirus. J VIrol. 80:4179–4182.
   Google Scholar
• Schmittel, A., Keilholz, U., Thiel, E., and Scheibenbogen, C. 2000. Quantification of tumor-specific T-lymphocytes with the ELISPOT assay. J Immunother. 23:289–295.
   PubMed Web of Science ®Google Scholar
• Schmitz, J. E., Simon, M. A., Kuroda, M. J., Lifton, M. A., Ollert, M. W., Vogel, C. W., Racz, P., Tenner-Racz, K., Scallon, B. J., Dalesandro, M., Ghrayeb, J., Rieber, E. P., Sasseville, V. G., and Reimann, K. A. 1999. A non-human primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibody. Am. J Pathol. 154:1923–1932.
   PubMedGoogle Scholar
• Schmitz, J. E., Zahn, R. C., Brown, C. R., Rett, M. D., Li, M., Tang, H., Pryputniewicz, S., Byrum, R. A., Kaur, A., Montefiori, D. C., Allan, J. S., Goldstein, S., and Hirsch, V. M. 2009. Inhibition of adaptive immune responses leads to a fatal clinical outcome in SIV-infected pigtailed macaques but not vervet African green monkeys. PLoS Pathog. 5:e1000691.
   Google Scholar
• Seder, R. A., Darrah, P. A., and Roederer, M. 2008. T-Cell quality in memory and protection: Implications for vaccine design. Nat. Rev. Immunol. 8:247–258.
   PubMed Web of Science ®Google Scholar
• Sequar, G., Britt, W. J., Lakeman, F. D., Lockridge, K. M., Tarara, R. P., Canfield, D. R., Zhou, S. S., Gardner, M. B., and Barry, P. A. 2002. Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: Pathogenesis. J Virol. 76:7661–7671.
   PubMed Web of Science ®Google Scholar
• Singh, A. S., Radu, C. G., and Ribas, A. 2010. PET imaging of the immune system: Immune monitoring at the whole body level. Q. J Nucl. Med. Mol. Imaging. 54:281–290.
   PubMedGoogle Scholar
• Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., and Panoskaltsis, N. 2006. Cytokine storm in a Phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. New Engl. J Med. 355:1018–1028.
   PubMed Web of Science ®Google Scholar
• Swack, N. S., and Hsiung, G. D. 1982. Natural and experimental simian cytomegalovirus infections at a primate center. J Med. Primatol. 11:169–177.
   PubMedGoogle Scholar
• Tichenor, J. N., Dumont, C., Coletti, K. S., LeSauteur, L., Calise, D. V., Christn-Piche, M. S., and Satterwhite, C. 2010. A 6-week study to determine the antibody response to FK-506-immunosuppressed cynomolgus monkeys following the subcutaneous administration of keyhole limpet hemocyanin and tetanus toxoid in the presence or absence of incomplete Freud’s adjuvant. The Toxicologist. Abstract # 1989.
   Google Scholar
• Vogel, P., Weigler, B. J., Kerr, H., Hendrickx, A. G., and Barry, P. A. 1994. Seroepidemiologic studies of cytomegalovirus infection in a breeding population of rhesus macaques. Lab. Anim. Sci. 44:25–30.
   PubMedGoogle Scholar
• Vollers, S. S., and Stern, L. J. 2008. Class II major histocompatibility complex tetramer staining: Progress, problems, and prospects. Immunology 123:305–313.
   PubMedGoogle Scholar
• Waldrop, S. L., Pitcher, C. J., Peterson, D. M., Maino, V. C., and Picker, L. J. 1997. Determination of antigen-specific memory/effector CD4+ T-cell frequencies by flow cytometry: Evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J Clin. Invest. 99:1739–1750.
   PubMed Web of Science ®Google Scholar
• Wiseman, R. W., Wojcechowskyj, J. A., Greene, J. M., Blasky, A. J., Gopon, T., Soma, T., Friedrich, T. C., O’ Connor, S. L., and O’ Connor, D. H. 2007. Simian immunodeficiency virus SIVmac239 infection of major histocompatibility complex-identical cynomolgus macaques from Mauritius. J Virol. 81:349–361.
   PubMedGoogle Scholar
• Wolfl, M., Kuball, J., Eyrich, M., Schlegel, P. G., and Greenberg, P. D. 2008. Use of CD137 to study the full repertoire of CD8+ T-cells without the need to know epitope specificities. Cytometry A 73:1043–1049.
   PubMed Web of Science ®Google Scholar
• Yue, Y., and Barry, P. A. 2008. Rhesus cytomegalovirus: A non-human primate model for the study of human cytomegalovirus. Adv. Virus Res. 72:207–226.
   PubMed Web of Science ®Google Scholar
• Yuzawa, K., Konishi, A., Takehana, K., Iino, Y., Ohnuki, A., Kobayashi, T., Fukao, K., and Ohkohchi, N. 2003. APC0576: A novel small molecule, immunosuppressive agent effective in primate models. Transplantation 75:1463–1468.
   PubMedGoogle Scholar
• Zaritskaya, L., Shurin, M. R., Sayers, T. J., and Malyguine, A. M. 2010. New flow cytometric assays for monitoring cell-mediated cytotoxicity. Expert Rev. Vaccines. 9:601–616.
   PubMed Web of Science ®Google Scholar
• Zuber, B., Quigley, M. F., Critchfield, J. W., Shacklett, B. L., Abel, K., Miller, C. J., Morner, A., Paulie, S., Ahlborg, N., and Sandberg, J. K. 2006. Detection of macaque perforin expression and release by flow cytometry, immunohistochemistry, ELISA, and ELISpot. J Immunol. Meth. 312:45–53.
   PubMed Web of Science ®Google Scholar